Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Stockholders' Deficit (Details 2)

v3.19.1
Note 5 - Stockholders' Deficit (Details 2) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Mar. 31, 2019
Mar. 31, 2018
Allocated Share-based Compensation Expense $ 1,086,000 $ 45,000 $ 1,492,000 $ 209,000
Research and Development Expense [Member]        
Allocated Share-based Compensation Expense 225,000 16,000 256,000 80,000
General and Administrative Expense [Member]        
Allocated Share-based Compensation Expense $ 861,000 $ 29,000 $ 1,236,000 $ 129,000